- Transobturator,
- Tension-free Vaginal Tape
- Mini-Slings
Vaginal Sling Market size was valued at USD 2,567.2 million in 2023 and is expected to grow at a CAGR of 9.7% from 2024-2030. Vaginal slings are surgical devices used to treat stress urinary incontinence (SUI) in women, a condition affecting approximately 200 million women globally. These procedures are crucial for improving the quality of life for SUI patients. The increasing prevalence of SUI, coupled with growing awareness about treatment options, drives the vaginal sling market. Additionally, the aging female population, more susceptible to pelvic floor disorders, is expected to boost market growth.
Technological advancements in sling materials, such as the development of biocompatible meshes, and minimally invasive surgical techniques contribute to market expansion by improving safety and efficacy. The market also benefits from increased healthcare expenditure and a growing focus on women's health in many countries. However, challenges like potential complications associated with mesh implants, including erosion and pain, and regulatory scrutiny in some regions may hinder market growth. The COVID-19 pandemic initially slowed market growth due to the postponement of elective surgeries, but the market has since shown signs of recovery. North America held the major market share in 2023 and is expected to dominate the global Vaginal Sling Market in the forecasted years.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The increasing prevalence of stress urinary incontinence among women is a significant driver for the vaginal sling market. SUI affects 10-20% of adult women globally, with prevalence increasing with age. The condition significantly impacts the quality of life, leading to higher demand for effective treatment options like vaginal slings. Factors contributing to the rise in SUI cases include obesity, childbirth, and menopause. Additionally, there has been growing awareness about pelvic floor disorders and available treatments, partly due to educational initiatives by healthcare providers and advocacy groups. This increased awareness has boosted overall demand for vaginal sling procedures. Additionally, technological advancements in materials and surgical techniques have improved outcomes and reduced complications, further driving market growth. For instance, the development of lightweight, macroporous meshes has reduced the risk of erosion and infection. Minimally invasive techniques, such as single-incision mini-slings, have gained popularity due to shorter recovery times and reduced post-operative pain. In 2019, the FDA ordered manufacturers to stop selling and distributing surgical mesh intended for transvaginal repair of pelvic organ prolapse, which has indirectly affected the vaginal sling market due to increased scrutiny of all mesh products. The market is also influenced by reimbursement policies, with favorable coverage in developed countries driving adoption. In contrast, limited reimbursement in developing regions may hinder market growth. The trend towards value-based healthcare is pushing manufacturers to demonstrate the long-term cost-effectiveness of their products.
Vaginal Sling Market was valued at USD 2,567.2 million in 2023 and is expected to grow at a CAGR of 9.7% from 2024 to 2030.
The Vaginal Sling Market is segmented based on Product, Incontinence type, Type, End-use and geography.
The leading players in the global Vaginal Sling Market are Boston Scientific Corporation, Coloplast A/S, C. R. Bard, Inc. (acquired by Becton, Dickinson and Company), Ethicon, Inc. (Johnson & Johnson), American Medical Systems (acquired by Boston Scientific), Cogentix Medical, Caldera Medical, Neomedic International, Promedon Group, A.M.I. GmbH.
Historic years considered for the market study are 2019-2022, 2023 is considered as the base year for market estimation, and Seven years forecast is presented from 2024 – 2030.
1.Executive Summary |
2.Global Vaginal Sling Market Introduction |
2.1.Global Vaginal Sling Market - Taxonomy |
2.2.Global Vaginal Sling Market - Definitions |
2.2.1.Product |
2.2.2.Incontinence |
2.2.3.Type |
2.2.4. End Use |
2.2.5.Region |
3.Global Vaginal Sling Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Vaginal Sling Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Vaginal Sling Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Transobturator, |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Tension-free Vaginal Tape |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Mini-Slings |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Vaginal Sling Market By Incontinence , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Stress |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Urge |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Mixed |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Vaginal Sling Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Midurethral |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Traditional |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Vaginal Sling Market By End Use, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Clinics |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. ASC |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
9.Global Vaginal Sling Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Vaginal Sling Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Transobturator, |
10.1.2.Tension-free Vaginal Tape |
10.1.3.Mini-Slings |
10.2. Incontinence Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Stress |
10.2.2.Urge |
10.2.3.Mixed |
10.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Midurethral |
10.3.2.Traditional |
10.4. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Clinics |
10.4.3.ASC |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Vaginal Sling Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis and ForecastBy Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Transobturator, |
11.1.2.Tension-free Vaginal Tape |
11.1.3.Mini-Slings |
11.2. Incontinence Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Stress |
11.2.2.Urge |
11.2.3.Mixed |
11.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Midurethral |
11.3.2.Traditional |
11.4. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Clinics |
11.4.3.ASC |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Vaginal Sling Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and ForecastBy Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Transobturator, |
12.1.2.Tension-free Vaginal Tape |
12.1.3.Mini-Slings |
12.2. Incontinence Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Stress |
12.2.2.Urge |
12.2.3.Mixed |
12.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Midurethral |
12.3.2.Traditional |
12.4. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Clinics |
12.4.3.ASC |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Vaginal Sling Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Analysis and ForecastBy Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Transobturator, |
13.1.2.Tension-free Vaginal Tape |
13.1.3.Mini-Slings |
13.2. Incontinence Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Stress |
13.2.2.Urge |
13.2.3.Mixed |
13.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Midurethral |
13.3.2.Traditional |
13.4. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Clinics |
13.4.3.ASC |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Vaginal Sling Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Analysis and ForecastBy Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Transobturator, |
14.1.2.Tension-free Vaginal Tape |
14.1.3.Mini-Slings |
14.2. Incontinence Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Stress |
14.2.2.Urge |
14.2.3.Mixed |
14.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Midurethral |
14.3.2.Traditional |
14.4. End Use Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Clinics |
14.4.3.ASC |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Boston Scientific Corporation |
15.2.2.Coloplast A/S |
15.2.3.R. Bard, Inc. (acquired by Becton, Dickinson and Company) |
15.2.4.Ethicon, Inc. |
15.2.5.Johnson & Johnson |
15.2.6.American Medical Systems (acquired by Boston Scientific) |
15.2.7.Cogentix Medical |
15.2.8.Caldera Medical |
15.2.9.Neomedic International |
15.2.10.Promedon Group |
15.2.11.M.I. GmbH |
16. Research Methodology |
17. Appendix and Abbreviations |